GI
TNGX icon

GAMMA Investing’s Tango Therapeutics TNGX Stock Holding History

GAMMA Investing’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27K Buy
863
+257
+42% +$6.35K ﹤0.01% 2680
2026
Q1 		$12.7K Buy
606
+129
+27% +$1.8K ﹤0.01% 2946
2025
Q4 		$4.23K Buy
477
+13
+3% +$112 ﹤0.01% 3354
2025
Q3 		$3.9K Buy
464
+399
+614% +$2.7K ﹤0.01% 3265
2025
Q2 		$333 Buy
+65
New +$161 ﹤0.01% 3680
2024
Q4 		– Sell
-508
Closed -$3.91K – 3827
2024
Q3 		$3.91K Buy
508
+438
+626% +$4.18K ﹤0.01% 2843
2024
Q2 		$601 Buy
70
+19
+37% +$147 ﹤0.01% 3171
2024
Q1 		$405 Sell
51
-28
-35% -$300 ﹤0.01% 3136
2023
Q4 		$928 Buy
+79
New +$686 ﹤0.01% 2810

Other funds holding TNGX

CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
DACS
Dymon Asia Capital (Singapore) Singapore $2.39B AUM 150.5% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
CG
Caprock Group Boise, Idaho $5.22B AUM 42.47% 1-Year Est. Return

GAMMA Investing's TNGX Position: Q2 2026 in Review

GAMMA Investing increased its Tango Therapeutics (TNGX) stake by 42% in Q2 2026, buying an estimated $6.35K and bringing the position to 863 shares worth $27K. The position accounts for ﹤0.01% of the portfolio, ranked #2680.

GAMMA Investing first reported a position in TNGX in Q4 2023 and has held it in 9 quarters since. 24 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

  • GAMMA Investing held 863 shares of Tango Therapeutics worth $27K as of Q2 2026.
  • GAMMA Investing bought 257 Tango Therapeutics shares in Q2 2026, an estimated $6.35K.
  • Tango Therapeutics made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #2680 holding.
  • GAMMA Investing first reported a position in Tango Therapeutics in Q4 2023 and has held it in 9 quarters since.
  • 24 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.